Clinical Trial Update: Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial update on ARQ-151 Cream showing safety and efficacy in adolescents and adults with atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ARQ-151 cream (ARQ-151)

Snippet

Sponsor: Arcutis Biotherapeutics, Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2023-02-13